CDC Data Modernization Efforts Accelerate Nation’s Ability to Detect and Rapidly Respond to Health Threats

Today the Centers for Disease Control and Prevention (CDC) launched its updated Public Health Data Strategy for 2024-2025 and a companion 2023 Lookback Report. First launched in 2023, the strategy outlines the data, technology, policy, and administrative actions essential to address challenges in data exchange between healthcare organizations and public health authorities and between state,..

Read more

CDC’s National Institute for Occupational Safety and Health’s Impact Wellbeing™ Campaign Releases Hospital-Tested Guide to Improve Healthcare Worker Burnout

As part of the first federal campaign to address healthcare worker burnout, the Centers for Disease Control and Prevention’s (CDC) National Institute for Occupational Safety and Health (NIOSH) today released an evidence-informed and actionable guide for the nation’s hospital leaders to improve healthcare worker wellbeing – Impact Wellbeing™ Guide: Taking Action to Improve Healthcare Worker..

Read more

CDC Statement on the President’s Fiscal Year 2025

Today, the Biden-Harris Administration released the President’s Budget for Fiscal Year (FY) 2025. The Centers for Disease Control and Prevention (CDC) budget request for FY 2025 includes $9.683 billion in discretionary budget authority, Prevention and Public Health Funds, and Public Health Service Evaluation Funds, which is $521.1 million over the FY 2023 appropriation. This budget..

Read more

CDC study shows effectiveness of RSV immunization for infants

New data released today in CDC’s MMWR show that nirsevimab, a long-acting monoclonal antibody product, was highly effective in protecting infants from hospitalizations associated with respiratory syncytial virus (RSV). RSV is the leading cause of hospitalization among infants in the United States, and this finding supports CDC’s recommendation to protect infants in their first RSV season by giving the infant nirsevimab if the mother did..

Read more

Older Adults Now Able to Receive Additional Dose of Updated COVID-19 Vaccine

Today, CDC Director Mandy Cohen endorsed the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendation for adults ages 65 years and older to receive an additional updated 2023-2024 COVID-19 vaccine dose. The recommendation acknowledges the increased risk of severe disease from COVID-19 in older adults, along with the currently available data on vaccine effectiveness. Previous CDC..

Read more